Dr. Lacey McIntosh introduces PET/CT.
- How functional imaging is different from anatomic imaging
- Different tracers - FDG, NAF, DOTATATE, AXUMIN, PSMA
- Limitations (size, lack of contrast in some places)
- Pitfalls - know expected physiologic uptake and other processes that cause uptake
- Future of PET - exciting implications for therapies
Resources:
- Kapoor, V., McCook, B. M., & Torok, F. S. (2004). An introduction to PET-CT imaging. Radiographics, 24(2), 523-543..
- Bar-Shalom, R., Valdivia, A. Y., & Blaufox, M. D. (2000, July). PET imaging in oncology. In Seminars in nuclear medicine (Vol. 30, No. 3, pp. 150-185). WB Saunders.
- Wallitt, K., Yusuf, S., Soneji, N., Khan, S. R., Win, Z., & Barwick, T. D. (2018). PET/CT in Oncologic Imaging of Nodal Disease: Pearls and Pitfalls: RadioGraphics Fundamentals| Online Presentation. RadioGraphics, 38(2), 564-565.
- Wang, G. X., Kurra, V., Gainor, J. F., Sullivan, R. J., Flaherty, K. T., Lee, S. I., & Fintelmann, F. J. (2017). Immune checkpoint inhibitor cancer therapy: spectrum of imaging findings. Radiographics, 37(7), 2132-2144.